Cart
sales@molnova.com
Tovinontrine
CAS No. 2062661-53-2
Tovinontrine( —— )
Catalog No. M35598 CAS No. 2062661-53-2
Tovinontrine (IMR-687) (IMR-687) is a potent and selective inhibitor of phosphodiesterase-9 (PDE9), designed to target sickle cell disease treatment.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 161 | Get Quote |
|
| 5MG | 250 | Get Quote |
|
| 10MG | 359 | Get Quote |
|
| 25MG | 563 | Get Quote |
|
| 50MG | 753 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameTovinontrine
-
NoteResearch use only, not for human use.
-
Brief DescriptionTovinontrine (IMR-687) (IMR-687) is a potent and selective inhibitor of phosphodiesterase-9 (PDE9), designed to target sickle cell disease treatment.
-
DescriptionTovinontrine (IMR-687) is a highly potent and selective phosphodiesterase-9 (PDE9) inhibitor specifically for the treatment of sickle cell disease. IC50s are 8.19 nM and 9.99 nM for PDE9A1 and PDE9A2, respectively.
-
In Vitro——
-
In VivoAnimal Model:HbSS-Townes mice on a 129/B6 background (10-12 weeks old) Dosage:30 mg/kg Administration:Dosed daily by gavage for 30 days Result:Resulted in fetal hemoglobin (HbF) induction, reduced hemolysis and reduced reticulocytosis.
-
Synonyms——
-
PathwayAngiogenesis
-
TargetPDE
-
RecptorPDE
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2062661-53-2
-
Formula Weight394.47
-
Molecular FormulaC21H26N6O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (253.50 mM; Ultrasonic )
-
SMILESC[C@@H]1CN(Cc2ncccn2)C[C@H]1c1cn2c(ncc2c(=O)[nH]1)C1CCOCC1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. James G McArthur, et al.A novel, highly potent and selective phosphodiesterase-9 inhibitor for the treatment of sickle cell disease. Haematologica. 2020 Mar;105(3):623-631.?
molnova catalog
related products
-
Tetomilast
Tetomilast (OPC-6535) is a superoxide anion production inhibitor that inhibits PDE4 and proinflammatory functions.
-
EMD57439
EMD57439 is a selective PDE-III inhibitor, showing no significant increase in c-AMP concentration and producing little change in Ca(50).
-
HA155
HA155 selectively and potently inhibits autotaxin with an IC50 of 5.7 nM.
